Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-045 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56994 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate |
2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09ef4db8a6d81547d2d90b5749f29d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06e33048662cf7fd066436d3ac0016dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7daed5b531833f4c651c2c08221e6e77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_969ea53ecfcbc044087273c138af3cb4 |
publicationDate |
2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014141406-A1 |
titleOfInvention |
Biomarkers for prenatal diagnosis of congenital cytomegalovirus |
abstract |
The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV-infected mothers and fetuses compared to uninfected individuals. |
priorityDate |
2007-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |